Clinical Trial Update: This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oblimersen (Genasense) in combination with rituximab and fludarabine for previously untreated chronic lymphocytic leukemia has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Genasense (oblimersen)
• Rituximab (rituximab)

Snippet

Sponsor: Genta Incorporated | Conditions: Lymphocytic Leukemia | Phase 3 | Status: WITHDRAWN